A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system

References

• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• DolecekTAProppJMStroupNEKruchkoCCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009Neuro Oncol201214Suppl 5v1v4923095881
   PubMed Web of Science ®Google Scholar
• AgarwalSSaneROberoiROhlfestJRElmquistWFDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brainExpert Rev Mol Med201113e1721676290
   PubMed Web of Science ®Google Scholar
• LiuDAugusteDTCancer targeted therapeutics: from molecules to drug delivery vehiclesJ Control Release201521963264326342659
   PubMed Web of Science ®Google Scholar
• StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
   PubMed Web of Science ®Google Scholar
• StanACCasaresSRaduDWalterGFBrumeanuTDDoxorubicin-induced cell death in highly invasive human gliomasAnticancer Res1999192A94195010368637
   PubMed Web of Science ®Google Scholar
• PradosMDScholdSCSpenceAMPhase II study of paclitaxel in patients with recurrent malignant gliomaJ Clin Oncol1996148231623218708723
   PubMed Web of Science ®Google Scholar
• KumthekarPGrimmSChandlerJA phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomasJ Neurooncol2017133358959428510787
   PubMed Web of Science ®Google Scholar
• PengYZhaoZLiuTSmart human-serum-albumin-As2O3 nanodrug with self-amplified folate receptor-targeting ability for chronic myeloid leukemia treatmentAngew Chem Int Ed Engl20175636108451084928686804
   PubMed Web of Science ®Google Scholar
• ZhangZLiuHZhouHA facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatmentNanoscale2016874373438026840759
   PubMed Web of Science ®Google Scholar
• CheungWMChuPWKwongYLEffects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cellsCancer Lett20072461–212212816569477
   PubMed Web of Science ®Google Scholar
• AkhtarAXiaoyan WangSGhaliLBellCWenXRecent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancersJ Biomed Res201731317718828808212
   PubMed Web of Science ®Google Scholar
• SunYWangCWangLDaiZYangKArsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cellsCell Mol Biol Lett2018231329610575
   PubMed Web of Science ®Google Scholar
• ChengYLiYMaCArsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunctionOncotarget2016711126821269226871293
   PubMed Web of Science ®Google Scholar
• ChenHMacdonaldRCLiSKrettNLRosenSTO’HalloranTVLipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug releaseJ Am Chem Soc200612841133481334917031934
   PubMed Web of Science ®Google Scholar
• SongXLLiuSJiangYTargeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain gliomaEur J Pharm Sci20179612914027644895
   PubMed Web of Science ®Google Scholar
• ZhouJMengRSuiXLiWYangBVarious tolerances to arsenic trioxide between human cortical neurons and leukemic cellsSci China C Life Sci200649656757217312995
   PubMedGoogle Scholar
• EmadiAGoreSDArsenic trioxide – an old drug rediscoveredBlood Rev2010244–519119920471733
   PubMed Web of Science ®Google Scholar
• AuWYKwongYLArsenic trioxide: safety issues and their managementActa Pharmacol Sin200829329630418298894
   PubMed Web of Science ®Google Scholar
• ChungEJChengYMorshedRFibrin-binding, peptide amphiphile micelles for targeting glioblastomaBiomaterials20143541249125624211079
   PubMed Web of Science ®Google Scholar
• WangHHuangQChangHXiaoJChengYStimuli-responsive dendrimers in drug deliveryBiomater Sci20164337539026806314
   PubMed Web of Science ®Google Scholar
• HsuHJBugnoJLeeSRHongSDendrimer-based nanocarriers: a versatile platform for drug deliveryWiley Interdiscip Rev Nanomed Nanobiotechnol201791e1409
   Web of Science ®Google Scholar
• LiZFanZXuYpH-Sensitive and thermosensitive hydrogels as stem-cell carriers for cardiac therapyACS Appl Mater Interfaces2016817107521076027064934
   PubMed Web of Science ®Google Scholar
• ZhangXYaoSLiuCJiangYTumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapyBiomaterials20153926928125468377
   PubMed Web of Science ®Google Scholar
• SaraswathyMKnightGTPillaSAshtonRSGongSMultifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapyColloids Surf B Biointerfaces201512659059725591850
   PubMed Web of Science ®Google Scholar
• QinJChenDHuHCuiQQiaoMChenBSurface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brainChem Pharm Bull20075581192119717666843
   PubMed Web of Science ®Google Scholar
• ZhanCMengQLiQFengLZhuJLuWCyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene deliveryChem Asian J201271919622072592
   PubMed Web of Science ®Google Scholar
• KimYMParkSCJangMKTargeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in αvβ3 integrin-overexpressing tumor cellsCarbohydr Polym20171741059106828821028
   PubMed Web of Science ®Google Scholar
• ZhuSQianLHongMZhangLPeiYJiangYRGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cellsAdv Mater20112312H84H8921360776
   PubMed Web of Science ®Google Scholar
• LiQXuWNovel anticancer targets and drug discovery in post genomic ageCurr Med Chem Anticancer Agents200551536315720261
   PubMedGoogle Scholar
• KesharwaniPIyerAKRecent advances in dendrimer-based nanovec-tors for tumor-targeted drug and gene deliveryDrug Discov Today201520553654725555748
   PubMed Web of Science ®Google Scholar
• LuongDKesharwaniPDeshmukhRPEGylated PAMAM dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene deliveryActa Biomater201643142927422195
   PubMed Web of Science ®Google Scholar
• LiuRSunMLiuXInterplay of stimuli-responsiveness, drug loading and release for a surface-engineered dendrimer delivery systemInt J Pharm20144621–210310724374220
   PubMedGoogle Scholar
• MaPSunYChenJEnhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugateDrug Deliv201825115316529282992
   PubMed Web of Science ®Google Scholar
• ThanhVMNguyenTHTranTVLow systemic toxicity nano-carriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug releaseMater Sci Eng C Mater Biol Appl20188229129829025661
   PubMed Web of Science ®Google Scholar
• Taghavi PourianazarNMutluPGunduzUBioapplications of poly(amidoamine) (PAMAM) dendrimers in nanomedicineJ Nanopart Res20141642342
   Web of Science ®Google Scholar
• BaiSAhsanFSynthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparinPharm Res200926353954819034631
   PubMed Web of Science ®Google Scholar
• BaiSThomasCRawatAAhsanFRecent progress in dendrimer-based nanocarriersCrit Rev Ther Drug Carrier Syst200623643749517425500
   PubMed Web of Science ®Google Scholar
• SaraivaCPraçaCFerreiraRSantosTFerreiraLBernardinoLNanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseasesJ Control Release2016235344727208862
   PubMed Web of Science ®Google Scholar
• ZhangLZhuSQianLPeiYQiuYJiangYRGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for gliomaEur J Pharm Biopharm201179223224021496485
   PubMed Web of Science ®Google Scholar
• XiaoXLiuYGuoMpH-Triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivoJ Biomater Appl2016311233527059495
   PubMed Web of Science ®Google Scholar
• FeiWZhangYHanSRGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinomaInt J Pharm20175191–225026228109899
   PubMed Web of Science ®Google Scholar
• OddoneNZambranaAITassanoMPorcalWCabralPBenechJCCell uptake mechanisms of PAMAM G4-FITC dendrimer in human myometrial cellsJ Nanopart Res20131571776
   Web of Science ®Google Scholar
• RussVGüntherMHalamaAOgrisMWagnerEOligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene deliveryJ Control Release2008132213114018812195
   PubMed Web of Science ®Google Scholar
• HeHLiYJiaXRPEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumorsBiomaterials201132247848720934215
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• ZhangJHanJZhangXPolymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxelCarbohydr Polym2015129253426050884
   PubMed Web of Science ®Google Scholar
• NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nanobio interfaceNat Mater20098754355719525947
   PubMed Web of Science ®Google Scholar
• BaeYHParkKTargeted drug delivery to tumors: myths, reality and possibilityJ Control Release2011153319820521663778
   PubMed Web of Science ®Google Scholar
• BerensonJRYehHSArsenic compounds in the treatment of multiple myeloma: a new role for a historical remedyClin Lymphoma Myeloma20067319219817229334
   PubMedGoogle Scholar
• BajGArnulfoADeaglioSArsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effectsBreast Cancer Res Treat2002731617312083632
   PubMed Web of Science ®Google Scholar
• MillerWHSchipperHMLeeJSSingerJWaxmanSMechanisms of action of arsenic trioxideCancer Res200262143893390312124315
   PubMed Web of Science ®Google Scholar
• ParkMJLeeJYKwakHJArsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen speciesJ Cell Biochem200595595596915962302
   PubMed Web of Science ®Google Scholar